• MG-132: Unlocking Proteostasis and Neurodegeneration Insi...

  2025-09-30

  Explore the advanced scientific applications of MG-132, a potent proteasome inhibitor peptide aldehyde, in dissecting protein degradation, autophagy, and neurodegenerative disease mechanisms. Discover unique perspectives on ubiquitin-proteasome system inhibition, cell cycle arrest, and apoptosis research beyond standard protocols.

• N1-Methylpseudouridine: Next-Gen mRNA Modification for Tr...

  2025-09-29

  Explore how N1-Methylpseudouridine revolutionizes mRNA translation enhancement by fine-tuning protein expression and modulating innate immune responses. This in-depth analysis offers a unique systems biology perspective, bridging molecular mechanisms with metabolic regulation for mRNA therapeutics research.

• Vorinostat (SAHA): Dissecting HDAC Inhibition and Mitocho...

  2025-09-28

  Explore how Vorinostat (suberoylanilide hydroxamic acid) enables advanced cancer biology research through precise HDAC inhibition, intrinsic apoptotic pathway activation, and unique insights into epigenetic modulation beyond transcriptional loss.

• Biotin-tyramide: Transforming Neurodevelopmental Imaging ...

  2025-09-27

  Explore how Biotin-tyramide revolutionizes enzyme-mediated signal amplification in neurodevelopmental research, enabling unprecedented resolution in immunohistochemistry and in situ hybridization. Discover distinct mechanistic insights, advanced application strategies, and integration with cutting-edge neurogenetic studies.

• SM-102: Optimizing Lipid Nanoparticles for Next-Gen mRNA ...

  2025-09-26

  Discover how SM-102 transforms lipid nanoparticles (LNPs) for efficient mRNA delivery and vaccine development. This article uniquely explores the molecular design, regulatory mechanisms, and translational potential of SM-102, advancing the conversation beyond predictive modeling.

• Anti Reverse Cap Analog (ARCA): Next-Generation mRNA Cap ...

  2025-09-25

  Discover how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, is transforming synthetic mRNA capping for enhanced translation and metabolic pathway engineering. This in-depth article uniquely explores ARCA’s role in advanced mRNA stability, translation initiation, and its intersection with mitochondrial metabolic regulation.

• FLAG tag Peptide (DYKDDDDK): Unlocking Precision in Recom...

  2025-09-24

  Discover how the FLAG tag Peptide (DYKDDDDK) revolutionizes recombinant protein purification and detection. This article offers a unique systems-level perspective on dissecting multi-motor protein complexes using this versatile epitope tag, with deep technical insights and practical guidance.

• Nonivamide as a TRPV1 Agonist: Novel Insights for Cancer ...

  2025-09-23

  Explore the scientific advances enabled by Nonivamide, a capsaicin analog and TRPV1 receptor agonist, in cancer cell growth inhibition and inflammation modulation. This article examines emerging molecular mechanisms and translational applications relevant to oncology and neuroimmunology.

• Canagliflozin Hemihydrate in Advanced Glucose Homeostasis...

  2025-09-22

  Explore the research applications of Canagliflozin hemihydrate, a small molecule SGLT2 inhibitor, in the context of glucose metabolism and metabolic disorder studies. This article examines its mechanistic specificity and recent evidence that distinguishes it in molecular pathway research.

• ARCA EGFP mRNA: Advances in Direct-Detection Reporter mRN...

  2025-09-19

  Explore the applications and technical benefits of ARCA EGFP mRNA as a direct-detection reporter mRNA for fluorescence-based transfection assays and mammalian cell gene expression studies. Learn how co-transcriptional capping with ARCA and Cap 0 structure enhance mRNA stability and transfection efficiency.

• Advancing Mammalian Expression: EZ Cap Cy5 Firefly Lucife...

  2025-09-18

  Explore the unique advantages of EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) for precise mRNA delivery and translation efficiency assays. This article highlights its Cap1 structure, Cy5 fluorescent labeling, and innate immune activation suppression in mammalian research applications.

• If the lack of specificity and the

  2025-04-22

  

  If the lack of specificity and the high pleiotropy may represent a problem in view of the potential chemotherapeutic features of autophagy-inducing agents, it Biotin-tyramide may switch into an advantage in the case of chemopreventive strategies. In fact, as non-pharmacologic interventions such as

• Compound was docked into the active site of Aurora B

  2025-04-22

  

  Compound was docked into the active site of Aurora B kinase using Tripos sybyl-X ver. 2.1.1. The crystal structure of human Aurora B kinase cocrystallized with its potent inhibitor VX-680 was used for the docking analysis (PDB ID: ). The most likely binding conformations were selected based on the

• In many cells AR mediated activation of PLC has been

  2025-04-21

  

  In many Y-27632 dihydrochloride α1-AR mediated activation of PLC has been shown to be the downstream process for NA-induced signalling. The activated PLC initiates subsequent signalling by breakdown of PIP2 to IP3 and DAG (Fisher and Agranoff, 1987) and the process continues. To confirm if such mech

• Recent studies have indicated that V

  2025-04-19

  

  Recent studies have indicated that V-ATPase activity negatively regulates vacuolar fusion in vivo[17]. Since we have demonstrated that the pah1Δ Biotin-tyramide have a more acidic vacuolar pH than the WT cells, and the genes involved in the pump activity are upregulated compared to WT, the pah1Δ cel

14121 records 1/942 page Next 12345 下5页 Last page